PRODUCT OVERVIEW

Skinlite Cream is a topical medicine used for the treatment of melasma, a skin condition characterized by dark patches on the face. It is intended for external use only and should be used under medical supervision for short term, intermittent treatment. The cream helps reduce skin pigmentation and improve the appearance of facial melasma when combined with proper sun protection.

KEY USES AND BENEFITS

Skinlite Cream is used for the treatment of melasma. Melasma commonly appears as dark patches on the face and is often associated with sun exposure and hormonal changes. The cream helps reduce excess melanin production and promotes skin cell turnover, allowing dark patches to fade more evenly. Regular use as prescribed, along with strict sun protection, can improve the appearance of affected skin.

COMPOSITION AND HOW IT WORKS

Skinlite Cream contains three active ingredients, Hydroquinone, Mometasone, and Tretinoin. Hydroquinone reduces excess melanin formation in the skin, helping to lighten dark patches. Mometasone is a corticosteroid that helps reduce inflammation, redness, and irritation associated with treatment. Tretinoin is a vitamin A derivative that promotes skin cell turnover, helping melanin disperse more evenly and improving skin appearance. Together, these ingredients work to reduce pigmentation and improve melasma when used under medical supervision.

DIRECTIONS FOR USE

Skinlite Cream is for external use only. Clean and dry the affected area before application. Apply a thin layer of the cream as directed by your doctor. Wash your hands after applying the cream unless your hands are the area being treated. Avoid contact with the eyes, mouth, and mucous membranes. Do not use more than the recommended amount or for a longer duration than prescribed.

SIDE EFFECTS

Common side effects of Skinlite Cream include burning, irritation, itching, redness, dryness, and a stinging sensation at the application site. Most side effects are mild and temporary and usually improve as the skin adjusts to treatment. Consult your doctor if these effects persist or worsen.

SAFETY ADVICE

Use Skinlite Cream only under medical supervision and for short term, intermittent treatment. Avoid direct sun exposure and ultraviolet light during treatment, as they may cause repigmentation of treated areas. Apply sunscreen regularly while using this medicine. The safety of this medicine has not been established during pregnancy or in children below 12 years of age. Breastfeeding women should use this medicine with caution and consult their doctor before use. Stop treatment and seek medical advice if severe irritation, hypersensitivity, or worsening of skin symptoms occurs.